Category: Boston Business Journal

Here’s one thing Charlie Baker should do to address opiate addiction

November 13th, 2014 in 2014, Boston Business Journal, Daniel Alford, Newsmakers, School of Medicine 0 comments

Alford_Dan-150x150Boston Business Journal
Daniel Alford, School of Medicine

As director of the SCOPE of Pain program at Boston University launched last year to address the rising problem of opiate addiction, Dan Alford is not anti-drug…

Expert quote:

“It’s very exciting, but not all that surprising, that (Baker) is choosing to focus on this. It’s in your face.”

View full article

Here’s an argument as to why drugmakers lie about the reasons drug cost so much

November 11th, 2014 in 2014, Alan Sager, Boston Business Journal, Newsmakers, School of Public Health 0 comments

asagerBoston Business Journal
Alan Sager, School of Public Health

Drug prices are a touchy subject in Massachusetts. On one hand, as a pioneer in efforts to increase health care coverage for everyone, the state needs to rein in out-of-control drug costs. On the other hand, as the global hub of biotech research, our economy depends on those high prices to generate the revenue to keep investors pumping money into our hundreds of companies…

Expert quote:

“When drugmakers say they set prices to pay for development costs, that’s 108 percent untrue. Those arguments are just an attempt to justify or rationalize costs.”

View full article

Why Boston entrepreneurs are betting on bitcoin

October 17th, 2014 in 2014, Bitcoin, Boston Business Journal, Mark Williams, Newsmakers, School of Management 0 comments

MarkWilliams1Boston Business Journal (subscription required)
Mark Williams, School of Management

About a year and a half ago, Jeremy Allaire started working on a startup whose aim is to make bitcoin, the digital currency known for its volatility and security issues, accepted around the world…

Expert quote:

“As the market gets better on the true inherent risk, the pricing will continue to fall. All the risk has not been priced into bitcoin.”

View full article

Officials convene opiate experts to address drug problem

September 5th, 2014 in 2014, Alexander Walley, Boston Business Journal, Newsmakers, School of Medicine 0 comments

walley1Boston Business Journal (subscription required)
Alexander Walley, School of Medicine

A slew of opiate experts were convened by the U.S. District Court Probation Office to address opiate addiction problem in the state…

Expert quote:

“The most visible and the most important issue is that people are dying from opiate overdoses. They are dying at high rates. It’s the number one cause of accidental injury death in the state and it has been for over 10 years. People are dying, that’s the tip of the iceberg.”

View full article

Here comes Wells Fargo

August 29th, 2014 in 2014, Boston Business Journal, Centers & Institutes in the News, Cornelius Hurley, Newsmakers, School of Law 0 comments

hurley11-150x150Boston Business Journal (subscription required)
Cornelius Hurley, School of Law, Center for Finance, Law & Policy

As Wells Fargo & Co. blanketed the country with its branches and ATMs over the years, most of New England has remained one step out of its aggressive retail expansion…

Expert quote:

“The problem is that Wells Fargo is considered a ‘too big to fail’ bank by the feds and I don’t think regulators would ever allow it to make such a big purchase like Citizens.”

View full article

Boston scientists develop analytics for stem cell engineering

August 26th, 2014 in 2014, Boston Business Journal, College of Engineering, James Collins, Newsmakers 0 comments

jcollins7Boston Business Journal
James Collins, College of Engineering

Scientists at Boston Children’s Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have developed a computer algorithm to test stem cells, a breakthrough that has allowed scientists to regrow part of a colon in a mouse…

Expert quote:

“We can assess how close the cell you’ve made is what you want it to be, and what else do you need to perturb to get it to the desired state.”

View full article

 

Atlas biotech gets $29M to create healing bacteria

July 22nd, 2014 in 2014, Boston Business Journal, College of Engineering, James Collins, Newsmakers 0 comments

jcollins7Boston Business Journal
James Collins, College of Engineering

Eight months after Flagship Ventureslaunched its biotech to develop drugs based on microorganisms in the human body, Atlas Venture today announced $29 million in financing for its entry into that field…

Expert quote:

“Bacteria have been shown to be an ideal vector for the production and delivery of drugs for many diseases – many bacteria already exist in a commensal or even mutualistic relationship with the human body, they already contain compounds and metabolic pathways that can release or produce drugs and a large proportion of diseases are bacterial. Our goal is simple – use the amazing potential of synthetic biology to play a critical role in the development of therapies that lead to improved clinical outcomes for patients.”

View full article

Frequent Facebook use could signal divorce on the way

June 3rd, 2014 in 2014, Boston Business Journal, College of Communication, James Katz, Newsmakers, RESEARCH @ BU 0 comments

KATZBoston Business Journal
James Katz, College of Communication

Facebook is a great way to maintain friendships, but heavy usage could be a step toward losing a marriage, according to a study published by a professor at Boston University…

View full article featuring expert James Katz

Addiction expert says launch of Zohydro was irresponsible

May 19th, 2014 in 2014, Boston Business Journal, Daniel Alford, Newsmakers, School of Medicine 0 comments

Alford_Dan-150x150Boston Business Journal
Daniel Alford, School of Medicine

The physician who oversees a statewide effort to train doctors on how to prescribe addictive painkillers safely said a San Diego drug firm was “irresponsible” to launch its opiate, Zohydro, before coming up with a formulation that makes it harder to abuse…

Expert quote:

“I agree with the limitations on Zohydro. I actually thought it was irresponsible to put it out there, because they didn’t learn the lessons from Oxycontin.”

View full article

BU School of Management launches ethics institute focused on Asia and the West

May 14th, 2014 in 2014, Boston Business Journal, BU in the News, BU Today, Newsmakers, School of Management 0 comments

Boston Business Journal

Boston University’s School of Management has created an ethics institute focused on the ethics of business practices in both western and eastern cultures, BU announced Tuesday. The ethics institute will be housed within the management school and endowed with a financial donation from Harry Susilo, founder of the Indonesia-based Sekar Group and All Bluesky Enterprise Pte Limited based in Singapore…

View full article